Healthcare Ventures
Welcome to Rothschild Corp’s Healthcare Ventures. We are at the forefront of transforming healthcare through innovation, advanced research, and sustainable practices. Our investments in healthcare span a diverse range of cutting-edge solutions designed to improve lives and address global health challenges
Live Well Pharmaceuticals
Live Well Pharmaceuticals specializes in the production of high-quality generic pharmaceuticals. Our commitment to affordability and accessibility ensures that essential medicines reach a broad population
Market Insights
The generic pharmaceuticals market is projected to reach USD 740.5 Billion by 2032, growing at a CAGR of 8.1% from 2024 to 2032
Innovation and Impact
We focus on developing cost-effective treatments for widespread health conditions, driving global health improvements
Tumulus Pharmaceuticals
Tumulus Pharmaceuticals specializes in the development and production of advanced blood products and biotechnological innovations. Our focus on cutting-edge research and development ensures the creation of vital therapies that address critical healthcare needs, making life-saving treatments more accessible to a global population.
Market Insights
The biotech healthcare market is expected to reach USD 3,879.51 Billion by 2031, with a CAGR of 13.9% from 2024 to 2031
Innovation and Impact
Our focus on biotechnological advancements positions us as leaders in innovative healthcare solutions
Myco-Medicine
The Synergistic Alliance of Tumulus Pharmaceuticals in Advancing Myco-Medicine
Myco-Medicine
Tumulus Pharmaceuticals partners with a biotech leader to advance research on liver disorders like Adenocarcinoma, using medicinal mushrooms for innovative health solutions.
Advancing Myco-Medicine
Rising demand for natural therapies boosts Tumulus Pharmaceuticals’ role in myco-medicine, addressing critical needs in liver health and cancer prevention.
Innovation and Impact
Developing products like Ganoderma extracts, this partnership blends traditional remedies with modern science, setting new standards in hepatobiliary care.
Sheep Placenta Cellular Therapy
Our Sheep Placenta Cellular Therapy division pioneers advanced cell therapy treatments, leveraging the regenerative properties of sheep placenta cells
Market Insights
The market size for sheep placenta cellular therapy is projected to be USD 70.47 million in 2024, growing at a CAGR of 8.27%
Innovation and Impact
We are at the cutting edge of regenerative medicine, offering novel therapies for cellular rejuvenation and healing
We have a wide range on newly launched products which include health supplements, skin care products and raw materials
Goji Berries
Market Insights
The Goji Berries market size is USD 341.6 million by 2031 and is expected to expand at a CAGR of 7.2% during the forecast period from 2024 to 2031. This growth is driven by the increasing global demand for Goji Berries, particularly in the medicine and food industries, as well as other applications.
Innovation and Impact
We are leading the way in harnessing the benefits of Goji Berries, offering innovative solutions that cater to the burgeoning demand for natural health products and supplements
Mushrooms
Market Insights
The Mushroom Market was valued at USD 50.3 billion in 2019 and is projected to grow from USD 55.18 billion in 2023 to USD 126.95 billion by 2031, with an anticipated CAGR of 9.7% during the forecast period (2024-2031).
Innovation and Impact
We are at the forefront of the mushroom industry, driving growth through advanced cultivation techniques, product diversification, and sustainable practices that meet the rising demand for mushrooms in various sectors